L 130
Alternative Names: Conjugated Psilocin™; L-130; Psilocin MucateLatest Information Update: 09 Oct 2024
At a glance
- Originator Lobe Sciences
- Class Analgesics; Behavioural disorder therapies; Indole alkaloids; Mood stabilisers; Small molecules; Tryptamines
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Unspecified
Most Recent Events
- 02 Oct 2024 Lobe Science files for patent protection for the compositions of matter, methods of use and methods of production for psilocin mucate worldwide
- 02 Oct 2024 Lobe Sciences has patent protection for Psilocin Mucate in USA
- 07 Dec 2023 Pharmacokinetics data from a phase I pharmacokinetic trial released by Lobe Sciences